# FDA Inspection 1210000 - Novo Nordisk A/S - G8, X9 M.FI - May 12, 2021

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-g8-x9-mfi/59abd04d-743c-426a-9d51-d1cbd26cf37d
Source feed: FDA_Inspections

> FDA Inspection 1210000 for Novo Nordisk A/S - G8, X9 M.FI on May 12, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210000
- Company Name: Novo Nordisk A/S - G8, X9 M.FI
- Inspection Date: 2021-05-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1297668 - 2022-06-16](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-g8-x9-mfi/a73b5e51-19ef-492f-93ba-175b269567c1)
- [FDA Inspection 1057701 - 2018-06-01](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-g8-x9-mfi/1f102aec-f9e4-4a48-a3e6-f4de0d409133)
- [FDA Inspection 965339 - 2016-04-14](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-g8-x9-mfi/a0e8e2a8-0bb2-44e9-93fe-d3cc08644638)
- [FDA Inspection 874067 - 2014-03-14](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-g8-x9-mfi/808f8b73-b95d-4ba2-a571-55269651a399)
- [FDA Inspection 746554 - 2011-09-08](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-g8-x9-mfi/3683a977-57f0-410c-9d89-4514c94a8b20)

Company: https://www.keypedia.com/companies/novo-nordisk-as-g8-x9-mfi/389db4db-1347-40e5-88ef-284fdcfa1a1d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c